Cabergoline versus bromocriptine for levodopa‐induced complications in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cabergoline Versus Bromocriptine for Levodopa‐induced Complications in Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438795/all/Adverse_side_effects_of_dexamethasone_in_surgical_patients:_Cochrane_systematic_review. Accessed 19 April 2024.
Cabergoline versus bromocriptine for levodopa‐induced complications in Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438795/all/Adverse_side_effects_of_dexamethasone_in_surgical_patients:_Cochrane_systematic_review. Accessed April 19, 2024.
Cabergoline versus bromocriptine for levodopa‐induced complications in Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438795/all/Adverse_side_effects_of_dexamethasone_in_surgical_patients:_Cochrane_systematic_review
Cabergoline Versus Bromocriptine for Levodopa‐induced Complications in Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438795/all/Adverse_side_effects_of_dexamethasone_in_surgical_patients:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cabergoline versus bromocriptine for levodopa‐induced complications in Parkinson's disease
ID - 438795
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438795/all/Adverse_side_effects_of_dexamethasone_in_surgical_patients:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -